[Elsevier] The Lancet Rheumatology

dessesseintes75 Post time 2024-4-26 08:15:08 | Show all posts |Read mode
Reward20points

Satoshi Ebata, Ayumi Yoshizaki, Koji Oba, Kosuke Kashiwabara, Keiko Ueda, Yukari Uemura, Takeyuki Watadani, Takemichi Fukasawa, Shunsuke Miura, Asako Yoshizaki-Ogawa, Naoko Okiyama, Masanari Kodera, Minoru Hasegawa, Shinichi Sato,Safety and efficacy of rituximab in systemic sclerosis (DESIRES): open-label extension of a double-blind, investigators-initiated, randomised, placebo-controlled trial,The Lancet Rheumatology,Volume 4, Issue 8,2022,Pages e546-e555,ISSN 2665-9913,https://doi.org/10.1016/S2665-9913(22)00131-X.

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
racks Post time 2024-4-26 08:15:09 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report


Senior Member
  • post

  • reply

  • points

    520

Latest Reply



Return to the list